Optiver Holding’s Bio-Techne TECH Stock Holding History

Optiver Holding’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-84	Closed	-$6.05K	–	1575
2024 Q4	$6.05K	Buy	+84	New	+$6.17K	﹤0.01%	836
2024 Q3	–	Sell	-452	Closed	-$32.4K	–	1086
2024 Q2	$32.4K	Buy	+452	New	+$33.3K	﹤0.01%	596

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Optiver Holding's TECH Position: Q1 2025 in Review

Optiver Holding sold out of Bio-Techne (TECH) in Q1 2025, closing a stake of 84 shares — an estimated $6.05K sold.

Optiver Holding first reported a position in TECH in Q2 2024 and held it in 2 quarters. The position peaked at $32.4K in Q2 2024. 577 funds tracked by Wall St. Rank hold TECH as of Q1 2025.

Optiver Holding reported no remaining Bio-Techne position as of Q1 2025 after selling out during the quarter.
Optiver Holding sold 84 Bio-Techne shares in Q1 2025, an estimated $6.05K.
Optiver Holding first reported a position in Bio-Techne in Q2 2024 and held it in 2 quarters.
Optiver Holding's Bio-Techne position peaked at $32.4K in Q2 2024.
577 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2025.

Based on Optiver Holding's 13F filing for Q1 2025, filed 15 May 2025.